key: cord-0972093-u0z0aaf1 authors: Sharif-Askari, Fatemeh Saheb; Sharif-Askari, Narjes Saheb; Goel, Swati; Hafezi, Shirin; Assiri, Rasha; Al-Muhsen, Saleh; Hamid, Qutayba; Halwani, Rabih title: SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway date: 2021-07-22 journal: Eur J Pharmacol DOI: 10.1016/j.ejphar.2021.174374 sha: 21def6803d8390b33a6261d50cded089ca453678 doc_id: 972093 cord_uid: u0z0aaf1 The efficacy of corticosteroids and its use for the treatment of SARS-CoV-2 infections is controversial. In this study, using data sets of SARS-CoV-2 infected lung tissues and nasopharyngeal swabs, as well as in vitro experiments, we show that SARS-CoV-2 infection significantly downregulates DUSP1 expression. This downregulation of DUSP1 could be the mechanism regulating the enhanced activation of MAPK pathway as well as the reported steroid resistance in SARS-CoV-2 infection. Moreover, chloroquine, an off labeled COVID-19 drug is able to induce DUSP1 and attenuate MAPK pathway; and is expected to improve sensitivity to steroid treatment. However, further mechanistic studies are required to confirm this effect. Novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) outbreak is a major 52 challenge for the whole world, and especially for clinicians. Approximately 5% to 10% of 53 the cases are critical and require admission to intensive care unit (Matthay et al., 2020). Little data exist that explain SARS-Cov-2 pathogenesis, and no pharmacological 55 therapies of proven efficacy yet exist. In this study, the expression levels of these glucocorticoid-dependent genes including 84 NR3C1, HDAC2, DUSP1 and TSC22D3 following SARS-CoV-2 infection was investigated. The datasets included are as follow; a dataset for SARS-CoV-2 infected HAECs For both SARS-CoV-2 and SARS-CoV-1 infections, the primary human airway epithelial 120 cells were cultured at the air-liquid interface, as described previously (Blanco-Melo et al., To understand the mechanism regulating response to steroid treatment following SARS- Early during COVID-19 pandemic, chloroquine has been widely used to treat severe 258 COVID-19 patients due to its observed immunosuppressive effect. However, the 259 mechanism behind this effect is not fully understood. Interestingly, analysis of a gene (Fig. 1E) . Therefore, induction of DUSP1 and TSC22D3 368 expression in SARS-CoV-2 infected lung tissues may represent a novel therapeutic 369 modality with the potential to inhibit inflammatory cytokine recruitment. In summary, we have observed that the expression level of DUSP1 and TSC22D3 is (n=4) that were randomly chosen from the 36 patient cohorts (Fig. 1D) . The data 606 presented shows increased expression of p-ERK 1/2 in COVID-19 nasopharyngeal swabs 607 as compared to healthy nasopharyngeal swabs; indicative of increased MAPK signaling. Statistical test: LogFC was determined using adjusted LIMMA and two-way comparison 609 was done using unpaired t-test or Mann-Whitney U test, depending on the skewness of 610 the data. ns=non-significant, * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001. TNF MAP3K8 DUSP8 RELB PDGFB IL1α NFKB2 IL1β DUSP5 HSPA1L MAPK12 CDC25B BDNF DUSP4 MAPK11 MAPK8IP2 NFKB1 IKBKG MAPK3 RPS6KA2 GNA12 MAP2K3 FGFR1 DUSP1 HSPA1A CACNB1 TGFB3 -2 -1 0 1 2 signal-to-noise ratio TNF MAP3K8 DUSP8 RELB PDGFB IL1α NFKB2 IL1β DUSP5 HSPA1L MAPK12 CDC25B BDNF DUSP4 MAPK11 MAPK8IP2 NFKB1 IKBKG MAPK3 RPS6KA2 GNA12 MAP2K3 FGFR1 DUSP1 HSPA1A CACNB1 signal-to-noise ratio J o u r n a l P r e -p r o o f ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☒The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Corticosteroid therapy for critically ill patients 427 with Middle East respiratory syndrome Plasma IL-431 6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill 432 COVID-19 patients Evidence of the COVID-19 Virus Targeting 434 the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic 435 Mechanisms Corticosteroid therapy for patients with COVID-19 438 pneumonia: a before-after study Corticosteroid effects on cell signalling Corticosteroid resistance in patients with asthma and chronic obstructive 441 pulmonary disease SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in 444 vivo systems Dual-specificity MAP kinase phosphatases (MKPs) Shaping the 446 outcome of MAP kinase signalling GILZ overexpression inhibits endothelial cell adhesive 449 function through regulation of NF-κB and MAPK activity 452 Dynamic regulation of pro-and anti-inflammatory cytokines by MAPK phosphatase in innate immune responses Statistical methods for identifying 456 differentially expressed genes in replicated cDNA microarray experiments Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA 460 expression profiling and in situ protein detection on TMAs reveal 15 sequentially 461 upregulated and 2 downregulated genes Respiratory syncytial virus represses glucocorticoid receptor-464 mediated gene activation Role of dual-specificity phosphatase 1 in glucocorticoid-466 driven anti-inflammatory responses Dexamethasone in hospitalized patients with Covid-19-469 preliminary report The data presented shows reduced level of this cytokine in 623 chloroquine treated as well as in chloroquine and dexamethasone treated fibroblasts 624 compared to untreated fibroblasts Log Fold change expression of glucocorticoid-dependent genes in HAECs of COPD (n=8) 629 or healthy controls (n=14) [GSE30351]. LogFC was determined using adjusted LIMMA. 630 ns=non-significant The data presented shows that a 635 significant lower level of DUSP1 was noticed in COVID-19's nasopharyngeal swabs with 636 high viral loads or SARS-CoV-2 N1 gene expression level (Pearson's r=0.092, P=0.031; 637 one-tailed test). Of note, the viral loads in these samples were determined by RT-PCR 638 that is, the greater the viral loads, the lower the Ct value. (B) The data presented shows 639 that there is no distinct pattern with level of TSC22D3 and viral loads in COVID-19's 640 nasopharyngeal swabs The data presented shows that a significant 645 lower level of DUSP1 was noticed in lung tissues with high viral loads (Spearman's r=-646 0.446, P=0.036; one-tailed test). (B) No distinct pattern was observed for level of 647 TSC22D3 and SARS-CoV-2 N1 gene in lung autopsies of COVID-19 patients Gene expression level, as measured by RT-PCR, of DUSP1 and TSC22D3 (GILZ) in chronic 653 obstructive pulmonary disease (COPD) bronchial fibroblasts (n=3), and in normal 654 bronchial fibroblasts (n=3). The data shows expression levels of these genes are lower in 655 COPD bronchial fibroblasts as compared to normal cells Baseline expression of DUSP1 in healthy liver and lung tissue extracted from the 660 Expression (GTEx) project. The data shows that the gene expression 661 levels of DUSP1 in liver tissues, on which the chloroquine has been tested Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., 2020. predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory 500viruses. PLoS ONE 8. 501Nehme, A., Cerutti, C., Zibara, K., 2016. Transcriptomic Analysis Reveals Novel Transcription 502Factors Associated With Renin-Angiotensin-Aldosterone System in Human Atheroma.